Celltrion submits IND for Phase 3 study of Prolia biosimilar in US
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
The company has conducted a Phase 1 trial of CT-P41 since August last year. Biosimilars usually skip Phase 2 trials because the administration and dosage have already been established by the reference drug.
The Phase 3 study is designed to enroll 416 patients in five countries with a goal of completion by the first half of 2024. The company aims to evaluate the safety and efficacy profile of CT-P41 in the clinical trial, and plants to go commercial in February 2025 when Prolia becomes off-patent.
Prolia is indicated for the treatment of postmenopausal women with osteoporosis and bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer. Amgen reported nearly $3 billion in sales from the drug in 2019.
Celltrion expects a high revenue contribution from a pipeline of CT-P41 and other investigational biosimilars in reference to blockbuster therapies such as Humira, Avastin, Xolair, and Stelara.
The company said it plans to speed up the ongoing global clinical trials and continue to provide high-quality and affordable biopharmaceuticals to the world.
[¨Ï Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- SK Innovation bumps up debt offering upon 7-times oversubscription - Pulse by Maeil Business News Korea
- ESG disclosure to be mandatory in phases for Kospi-listed firms - Pulse by Maeil Business News Korea
- Tesla cars to employ KT’s connected vehicle service in Korea - Pulse by Maeil Business News Korea
- Samsung takes center stage at CES with 173 awards - Pulse by Maeil Business News Korea
- Chong Kun Dang’s Covid-19 cure shows positive results in Phase 2 trial - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 총선 이후 부동산 정책 변화 짚어보니 [COVER STORY]
- “‘음악’으로 맺어진 ♥”…윤보미·라도, 8년째 열애 ‘인정’(종합)[MK★이슈] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이